AbbVie
ABBV
#27
Rank
C$538.87 B
Marketcap
$305.25
Share price
1.17%
Change (1 day)
26.94%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2024 (TTM): C$4.87 Billion

According to AbbVie's latest financial reports the company's current earnings are C$56.33 Billion. a decrease over its 2023 earnings that were of C$9.02 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2024

Annual earnings

Year Earnings Change
2024 C$5.36 B-40.54%
2023 C$9.02 B-53.62%
2022 C$19.45 B3.76%
2021 C$18.74 B282.25%
2020 C$4.90 B-59.67%
2019 C$12.16 B62.13%
2018 C$7.50 B-32.74%
2017 C$11.15 B-1.99%
2016 C$11.37 B18.65%
2015 C$9.59 B180.5%
2014 C$3.41 B-55.57%
2013 C$7.69 B-6.86%
2012 C$8.26 B56.05%
2011 C$5.29 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$10.02 B 86.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$12.1 Billion-325.48%๐Ÿ‡บ๐Ÿ‡ธ USA
C$18.30 B 241.24%๐Ÿ‡บ๐Ÿ‡ธ USA
C$6.65 B 24.03%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.25 B-95.26%๐Ÿ‡บ๐Ÿ‡ธ USA
C$2.75 B-48.71%๐Ÿ‡บ๐Ÿ‡ธ USA
C$6.02 B 12.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$15.05 B 180.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$0.74 B-86.19%๐Ÿ‡บ๐Ÿ‡ธ USA